Press Releases
Square 1 Bank Announces $2.25M Debt Facility to Carolus Therapeutics
Square 1 Bank the premier banking partner to entrepreneurs and the venture capital community today announced it has provided a $2.25M debt facility to new client Carolus Therapeutics a biopharmaceutical company. The financing will support future growth. ...
Press Releases
Dotmatics teams with leading distributor to launch powerful life science informatics platform
Dotmatics leading supplier of enterprise life science informatics solutions announces the appointment of Shanghai Budou Technology as their Chinese distributor. The partnership will make Dotmatics’ versatile informatics platform available to a large new market...
Press Releases
KSI & RFIDeas Introduce an Integrated Solution for ePrescribe
RFIDeas the innovator of WaveID® and KSI Inc. will introduce the first compliant ePrescribe keyboard for controlled substances at this year's HIMSS Annual Conference & Exhibition held in New Orleans March 3-7 2013. RFIDeas...
Press Releases
Novozymes Biopharma’s rAlbumin approved in Japan as MAQUET expands into new market
Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has announced that one of its leading customers has achieved approval of a medical device in Japan using Recombumin® Alpha - formerly Albucult®, a recombinant human albumin...
Press Releases
Promethera Biosciences opens the French part of its clinical trial in cell therapy
Promethera Biosciences, a Belgian biotechnology company developing Promethera(R) HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announces today that it has successfully treated a patient with liver progenitor...
Press Releases
Trophos announces positive interim review in pivotal study of olesoxime in Spinal Muscular Atrophy
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for under-served medical needs in neurology and cardiology, announces today the completion of the interim analysis of the pivotal efficacy study of olesoxime...
Press Releases
Okairos Initiates Phase I Clinical Trial Evaluating Vaccine against RSV Infections
Okairos today announced the initiation of a Phase I clinical trial evaluating a vaccine against respiratory syncytial virus (RSV), a leading cause of hospital admissions in infants and children. This clinical trial will enroll 40 healthy adult volunteers...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read